T. Rowe's $19 billion bond bet moves target-date fight into the sleeves
The F/m deal buys the fixed-income engine CITs demand. PGIM's private-markets hire shows the next front is inside the fund.
T. Rowe Price is paying $19 billion for F/m, a fixed-income shop whose bond ETFs and managed-account platform will become the core of its target-date retirement business. The price makes sense only because collective investment trusts now hold 55 percent of target-date assets. That pool is worth $5.3 trillion.
The acquisition, announced this week, makes clear that the target-date battleground has moved from the recordkeeper's shelf to the construction inside the fund. A CIT committee does not hire a brand. It hires a glidepath, a bond sleeve, a private-assets allocation, and a fee schedule. That is where the next competitive war will be fought.
Target-date assets grew 11% in the first half, according to Sway Research. The total now tops $5.3 trillion. Income-linked target-dates grew 18% over the same stretch. Collective investment trusts run 55% of that money.
The default demands efficiency, and efficiency starts with the sleeves. When a sponsor compares two CITs, it is comparing their bond sleeves, their private credit allocations, and their manager-specific alpha. The wrapper is a given.
For a generation, target-date funds were sold as a package: a glidepath engineered from a life-cycle model, a few index funds underneath, a brand that a plan committee trusted. The CIT has changed that package. Because a CIT sits outside the Investment Company Act, it has no prospectus and no load structure. It is priced by the trust's board and compared by sponsors on net return and fee. The logic pushes competition down to the level of the individual holding.
CITs have been gaining share for a decade, but 55% is a tipping point. Every legacy mutual fund target-date series still on a plan menu now faces a CIT alternative that undercuts it on fees. The managers that control both formats can arbitrage the conversion wave; the managers that only have mutual funds are on the wrong side of the trade.
Inside the CIT, the bond sleeve is the product
The bond sleeve used to be a passive aggregate index. Now it is a place to add yield and manage sequence risk. T. Rowe's purchase of F/m gives it the tools to build that sleeve in-house rather than rent it from a competitor. The same logic is pushing PGIM into private markets.
PGIM, Prudential's asset management arm, hired Yaqub Ahmed this week to run its defined contribution solutions business. Ahmed is a 30-year retirement industry veteran. PWD's tracking of the move shows his mandate includes bringing private markets into target-date CITs.
PGIM does not own a recordkeeper, so its DC strategy runs through other firms' trust platforms. That makes the sleeve the only place it can differentiate.
The private-markets piece is the harder engineering problem. A CIT that holds private credit or infrastructure needs semiannual valuation, redemption gates, and a recordkeeping system that can price a unit without a daily market. Most target-date providers have avoided that complexity. PGIM is building for the day when a 10% private-assets sleeve is a standard feature of the largest CITs. If income-linked target-dates keep growing at 18%, the day is closer than the flow data suggest. The valuation problem is the last engineering barrier, and the firm that solves it first gets the multiyear mandate.
Vanguard's move this week to let advisers customize its model portfolios through Vestmark, SS&C Black Diamond, and Orion is the same story from the opposite direction. Customization breaks the one-size-fits-all glidepath. Let a plan sponsor or adviser adjust the bond sleeve for a workforce nearing retirement, and the wrapper matters far less than the components inside it. Vestmark and Orion are the rails that make that customization possible. Vanguard is betting that the advisers who use them will want to tailor rather than just subscribe.
F/m's managed-account technology is the other half of the customization story. A target-date CIT that can rebalance each participant's fixed-income sleeve to a specific retirement date, or to a specific income need, is the product income-linked target-dates are trying to become. T. Rowe is buying the infrastructure before demand arrives.
This is a subscriber feature.
The full piece — and every PWD feature — is free for Morning Brief readers.